SEC Form 4 · accession 0001127602-17-023729
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Massaro
Director
Period of report
Jul 17, 2017
Accepted (ET)
Jul 18, 2017 · 12:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 17, 2017 | M | 4,030 | $43.39 | A | 18,731 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.26 | D | 18,631 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.46 | D | 18,531 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.52 | D | 18,431 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.54 | D | 18,331 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.59 | D | 18,231 | D | |
| Common Stock | Jul 17, 2017 | S | 1 | $100.61 | D | 18,230 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.63 | D | 18,130 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.64 | D | 18,030 | D | |
| Common Stock | Jul 17, 2017 | S | 200 | $100.65 | D | 17,830 | D | |
| Common Stock | Jul 17, 2017 | S | 224 | $100.67 | D | 17,606 | D | |
| Common Stock | Jul 17, 2017 | S | 95 | $100.70 | D | 17,511 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.71 | D | 17,411 | D | |
| Common Stock | Jul 17, 2017 | S | 10 | $100.72 | D | 17,401 | D | |
| Common Stock | Jul 17, 2017 | S | 200 | $100.78 | D | 17,201 | D | |
| Common Stock | Jul 17, 2017 | S | 200 | $100.80 | D | 17,001 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.81 | D | 16,901 | D | |
| Common Stock | Jul 17, 2017 | S | 200 | $100.82 | D | 16,701 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.84 | D | 16,601 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.85 | D | 16,501 | D | |
| Common Stock | Jul 17, 2017 | S | 200 | $100.87 | D | 16,301 | D | |
| Common Stock | Jul 17, 2017 | S | 300 | $100.89 | D | 16,001 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.91 | D | 15,901 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.92 | D | 15,801 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.93 | D | 15,701 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $100.96 | D | 15,601 | D | |
| Common Stock | Jul 17, 2017 | S | 200 | $100.97 | D | 15,401 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $101.00 | D | 15,301 | D | |
| Common Stock | Jul 17, 2017 | S | 300 | $101.15 | D | 15,001 | D | |
| Common Stock | Jul 17, 2017 | S | 100 | $101.32 | D | 14,901 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $43.39 | Jul 17, 2017 | M | 4,030 | D | May 8, 2014 | May 8, 2020 | Common Stock | 4,030 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.